Entera Bio Ltd. (ENTX) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 39 days, typically, give or take 22 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Fri, Nov 6, 2026after close 37 8-K
Q2 FY2026Fri, Aug 7, 2026after close 38 8-K
Q1 FY2026Fri, May 8, 2026after close 38 8-K
Q4 FY2025Fri, Mar 27, 2026after close 86 8-K
Q3 FY2025Fri, Nov 14, 2025after close 45 8-K
Q2 FY2025Fri, Aug 8, 2025after close 39 8-K
Q1 FY2025Fri, May 9, 2025after close 39 8-K
Q4 FY2024Fri, Mar 28, 2025after close 87 8-K

What they guided beta

Q3 FY2026 "Clinical Preparations Advanced for EB613 Phase 3 Osteoporosis Study, with First Site Activation Expected in Late 2026" exhibit
Q3 FY2026 "Our team is fully focused on ensuring a seamless trial launch, with expected first site activation in late 2026." exhibit
Q3 FY2026 "Additionally, the post-hoc analysis that we presented at ASBMR 2026 demonstrated that our Phase 2 6-month clinical data with EB613 show rapid stimulation of bone formation and robust early bone mineral density (BMD) accrual, especially in patients who start with lower BMD and who need the largest gains." exhibit
Q3 FY2026 "The Company’s cash resources are expected to be sufficient to fully fund the planned Phase 3 registrational program of EB613 through topline results and the anticipated submission of an NDA to the FDA and to support the Company’s operations into 2030." exhibit
Q2 FY2026 "On a pro forma basis, following the closing of the July 2026 private placement in which the Company received aggregate gross proceeds of approximately $275.0 million, the Company’s cash resources are expected to be sufficient to fully fund the planned Phase 3 registrational program of EB613 through topline results and the anticipated submission of an NDA to the FDA and to support the Company’s operations into 2030." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/ENTX
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/ENTX

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

ENTX earnings date badge

HTML

<a href="https://veritasdata.dev/company/ENTX/"><img src="https://veritasdata.dev/embed/ENTX.svg" alt="ENTX earnings date" width="240" height="56"></a>

Markdown

[![ENTX earnings date](https://veritasdata.dev/embed/ENTX.svg)](https://veritasdata.dev/company/ENTX/)

Script

<script async src="https://veritasdata.dev/embed/ENTX.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/ENTX"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.